July 22, 2022 Comments Off on New patent for Pf Prism drug INLYTA Posted in: Patent Added Annual Drug Patent Expirations for INLYTA Inlyta is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are four…
The post New patent for Pf Prism drug INLYTA appeared first on DrugPatentWatch – Make Bet…
July 22, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
